The multifaceted roles of PRDM16: Adipose biology and beyond

Trends in Endocrinology and Metabolism

Volumn 27, Issue 1, 2016, Pages 11-23

  Chi, Jingyi ^a   Cohen, Paul ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Adipose; Beige fat; Brown fat; PRDM; PRDM16; Transcriptional regulation

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; MICRORNA; TRANSFORMING GROWTH FACTOR BETA; DNA BINDING PROTEIN; PRDM16 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE CELL; BEIGE ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; COMPLEX FORMATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; WHITE ADIPOSE TISSUE; ANIMAL; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; DNA-BINDING PROTEINS; HUMANS; MUTATION; TRANSCRIPTION FACTORS;

EID: 84952636495     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.11.005     Document Type: Review

References (93)

1. Hohenauer T., Moore A.W. The Prdm family: expanding roles in stem cells and development. Development 2012, 139:2267-2282.
2. Fog C.K., et al. PRDM proteins: Important players in differentiation and disease. Bioessays 2012, 34:50-60.
3. Martins G., Calame K. Regulation and functions of Blimp-1 in T and B lymphocytes. Annu. Rev. Immunol. 2008, 26:133-169.
4. Küçük C., et al. PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:20119-20124.
5. Nakaki F., et al. Induction of mouse germ-cell fate by transcription factors in vitro. Nature 2013, 501:222-226.
6. Chittka A., et al. Transcription factor positive regulatory domain 4 (PRDM4) recruits protein arginine methyltransferase 5 (PRMT5) to mediate histone arginine methylation and control neural stem cell proliferation and differentiation. J. Biol. Chem. 2012, 287:42995-43006.
7. Inoue M., et al. Deletion of Prdm8 impairs development of upper-layer neocortical neurons. Genes Cells 2015, 20:758-770.
8. Inoue M., et al. Prdm8 regulates the morphological transition at multipolar phase during neocortical development. PLoS ONE 2014, 9:e86356.
9. Ross S.E., et al. Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly. Neuron 2012, 73:292-303.
10. Nagy V., et al. The evolutionarily conserved transcription factor PRDM12 controls sensory neuron development and pain perception. Cell Cycle 2015, 14:1799-1808.
11. Chen Y-C., et al. Transcriptional regulator PRDM12 is essential for human pain perception. Nat. Genet. 2015, 47:803-808.
12. Thélie A., et al. Prdm12 specifies V1 interneurons through cross-repressive interactions with Dbx1 and Nkx6 genes in Xenopus. Development 2015, 142:3416-3428.
13. Chang J.C., et al. Prdm13 mediates the balance of inhibitory and excitatory neurons in somatosensory circuits. Dev. Cell 2013, 25:182-195.
14. Hanotel J., et al. The Prdm13 histone methyltransferase encoding gene is a Ptf1a-Rbpj downstream target that suppresses glutamatergic and promotes GABAergic neuronal fate in the dorsal neural tube. Dev. Biol. 2014, 386:340-357.
15. Watanabe S., et al. Prdm13 regulates subtype specification of retinal amacrine interneurons and modulates visual sensitivity. J. Neurosci. 2015, 35:8004-8020.
16. Pastural E., et al. RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines. Oncogene 2006, 26:1586-1594.
17. Liu Z.Y., et al. Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas. Oncogene 2013, 32:1216-1222.
18. Shu X., et al. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating wnt/β-catenin signaling and is frequently silenced in multiple tumors. PLoS ONE 2011, 6:e27346.
19. Pinheiro I., et al. Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. Cell 2012, 150:948-960.
20. Kim K-C., et al. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res. 2003, 63:7619-7623.
21. Eom G.H., et al. Histone methyltransferase PRDM8 regulates mouse testis steroidogenesis. Biochem. Biophys. Res. Commun. 2009, 388:131-136.
22. Wu H., et al. Molecular basis for the regulation of the H3K4 methyltransferase activity of PRDM9. Cell Rep. 2013, 5:13-20.
23. Wu Y., et al. PRDM6 is enriched in vascular precursors during development and inhibits endothelial cell proliferation, survival, and differentiation. J. Mol. Cell. Cardiol. 2008, 44:47-58.
24. Győry I., et al. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat. Immunol. 2004, 5:299-308.
25. Ancelin K., et al. Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat. Cell Biol. 2006, 8:623-630.
26. Nishikata I., et al. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. Blood 2003, 102:3323-3332.
27. Seale P., et al. Transcriptional control of brown fat determination by PRDM16. Cell Metab. 2007, 6:38-54.
28. Rosen E.D., Spiegelman B.M. What we talk about when we talk about fat. Cell 2014, 156:20-44.
29. Tontonoz P., et al. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
30. Puigserver P., et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
31. Uldry M., et al. Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation. Cell Metab. 2006, 3:333-341.
32. Seale P., et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008, 454:961-967.
33. Wu J., et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012, 150:366-376.
34. Cohen P., Spiegelman B.M. Brown and beige fat: molecular parts of a thermogenic machine. Diabetes 2015, 64:2346-2351.
35. Seale P., et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. J. Clin. Invest. 2011, 121:96-105.
36. Cohen P., et al. Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell 2014, 156:304-316.
37. Harms M.J., et al. Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice. Cell Metab. 2014, 19:593-604.
38. Kajimura S., et al. Regulation of the brown and white fat gene programs through a PRDM16/CtBP transcriptional complex. Genes Dev. 2008, 22:1397-1409.
39. Kajimura S., et al. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-β transcriptional complex. Nature 2009, 460:1154-1158.
40. Ohno H., et al. EHMT1 controls brown adipose cell fate and thermogenesis through the PRDM16 complex. Nature 2013, 504:163-167.
41. Dempersmier J., et al. Cold-onducible Zfp516 activates UCP1 transcription to promote browning of white fat and development of brown fat. Mol. Cell 2015, 57:235-246.
42. Villanueva C.J., et al. Adipose subtype-selective recruitment of TLE3 or Prdm16 by PPARγ specifies lipid storage versus thermogenic gene programs. Cell Metab. 2013, 17:423-435.
43. Harms M.J., et al. PRDM16 binds MED1 and controls chromatin architecture to determine a brown fat transcriptional program. Genes Dev. 2015, 29:298-307.
44. Iida S., et al. PRDM16 enhances nuclear receptor-dependent transcription of the brown fat-specific Ucp1 gene through interactions with Mediator subunit MED1. Genes Dev. 2015, 29:308-321.
45. Trajkovski M., et al. MyomiR-133 regulates brown fat differentiation through Prdm16. Nat. Cell Biol. 2012, 14:1330-1335.
46. Liu W., et al. miR-133a regulates adipocyte browning in vivo. PLoS Genet. 2013, 9:e1003626.
47. Yin H., et al. MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16. Cell Metab. 2013, 17:210-224.
48. Chou C-F., et al. KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression. Diabetes 2014, 63:2949-2961.
49. Sun L., Trajkovski M. MiR-27 orchestrates the transcriptional regulation of brown adipogenesis. Metabolism 2014, 63:272-282.
50. Sun L., et al. Mir193b-365 is essential for brown fat differentiation. Nat. Cell Biol. 2011, 13:958-965.
51. Chuikov S., et al. Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress. Nat. Cell Biol. 2010, 12:999-1006.
52. Aguilo F., et al. Prdm16 is a physiologic regulator of hematopoietic stem cells. Blood 2011, 117:5057-5066.
53. Bjork B.C., et al. Prdm16 is required for normal palatogenesis in mice. Hum. Mol. Genet. 2010, 19:774-789.
54. Arndt A-K., et al. Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. Am. J. Hum. Genet. 2013, 93:67-77.
55. Zaveri H.P., et al. Identification of critical regions and candidate genes for cardiovascular malformations and cardiomyopathy associated with deletions of chromosome 1p36. PLoS ONE 2014, 9:e85600.
56. Duhoux F.P., et al. PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies: PRDM16 (1p36) translocations. Br. J. Haematol. 2012, 156:76-88.
57. Masetti R., et al. Whole transcriptome sequencing of a paediatric case of de novo acute myeloid leukaemia with del (5q) reveals RUNX1-USP42 and PRDM16-SKI fusion transcripts. Br. J. Haematol. 2014, 166:449-452.
58. Sakai I., et al. NovelRUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22). Genes. Chromosomes Cancer 2005, 44:265-270.
59. Stevens-Kroef M.P., et al. Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t (1; 21)(p36; q22)-positive therapy-related AML. Leukemia 2006, 20:1187-1189.
60. Mochizuki N., et al. A novel gene, MEL1, mapped to 1p36. 3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t (1; 3)(p36; q21)-positive leukemia cells. Blood 2000, 96:3209-3214.
61. Xiao Z., et al. MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21). Leuk. Res. 2006, 30:332-334.
62. Yoshida M., et al. Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood 2004, 103:2753-2760.
63. Shing D.C., et al. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice. J. Clin. Invest. 2007, 117:3696-3707.
64. Nishikata I., et al. Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation. Oncogene 2011, 30:4194-4207.
65. Yu H., et al. Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo. Blood 2014, 124:1737-1747.
66. Jo A., et al. High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML. Leukemia 2015, 29:1076-1083.
67. Glass C., et al. The role of EVI1 in myeloid malignancies. Blood Cells Mol. Dis. 2014, 53:67-76.
68. Kataoka K., Kurokawa M. Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis. Cancer Sci. 2012, 103:1371-1377.
69. Takahata M., et al. SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells. J. Biol. Chem. 2009, 284:3334-3344.
70. Warner D.R., et al. PRDM16/MEL1: a novel Smad binding protein expressed in murine embryonic orofacial tissue. Biochim. Biophys. Acta 2007, 1773:814-820.
71. Izutsu K., et al. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling. Blood 2001, 97:2815-2822.
72. Sood R., et al. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1. Leukemia 1999, 13:348-357.
73. Ohno H., et al. PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab. 2012, 15:395-404.
74. Kir S., et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 2014, 513:100-104.
75. Petruzzelli M., et al. A wwitch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 2014, 20:433-447.
76. Chang L., et al. Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-γ deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation 2012, 126:1067-1078.
77. Dong M., et al. Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis. Cell Metab. 2013, 18:118-129.
78. Carling T., et al. A histone methyltransferase is required for maximal response to female sex hormones. Mol. Cell. Biol. 2004, 24:7032-7042.
79. Goyama S., et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell 2008, 3:207-220.
80. Kataoka K., et al. Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. J. Exp. Med. 2011, 208:2403-2416.
81. Kurokawa M., et al. The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death. EMBO J. 2000, 19:2958-2968.
82. Chittka A. The p75NTR-interacting protein SC1 inhibits cell cycle progression by transcriptional repression of cyclin E. J. Cell Biol. 2004, 164:985-996.
83. Duan Z., et al. Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5. Mol. Cell. Biol. 2007, 27:6889-6902.
84. Burkitt Wright E.M.M., et al. Mutations in PRDM5 in brittle cornea syndrome identify a pathway regulating extracellular matrix development and maintenance. Am. J. Hum. Genet. 2011, 88:767-777.
85. Meani N., et al. The tumor suppressor PRDM5 regulates Wnt signaling at early stages of zebrafish development. PLoS ONE 2009, 4:e4273.
86. Davis C.A., et al. PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol. Cell. Biol. 2006, 26:2626-2636.
87. Jung C.C., et al. Transcription factor PRDM8 is required for rod bipolar and type 2 OFF-cone bipolar cell survival and amacrine subtype identity. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E3010-E3019.
88. Hayashi K., et al. A histone H3 methyltransferase controls epigenetic events required for meiotic prophase. Nature 2005, 438:374-378.
89. Baudat F., et al. PRDM9 is a major determinant of meiotic recombination hotspots in humans and mice. Science 2010, 327:836-840.
90. Park J-A., Kim K-C. Expression patterns of PRDM10 during mouse embryonic development. BMB Rep. 2010, 43:29-33.
91. Fog C.K., et al. Loss of PRDM11 promotes MYC-driven lymphomagenesis. Blood 2015, 125:1272-1281.
92. Satoh A., et al. Deficiency of Prdm13, a dorsomedial hypothalamus-enriched gene, mimics age-associated changes in sleep quality and adiposity. Aging Cell 2015, 14:209-218.
93. Nakaki F., Saitou M. PRDM14: a unique regulator for pluripotency and epigenetic reprogramming. Trends Biochem. Sci. 2014, 39:289-298.